Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism A2bR antagonists(Adenosine A2b receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Preclinical | India | 07 Sep 2022 | |
Melanoma | Preclinical | India | 07 Sep 2022 | |
Prostatic Cancer | Preclinical | India | 07 Sep 2022 | |
Allergic asthma | Preclinical | India | 10 Jul 2020 | |
Anemia, Sickle Cell | Preclinical | India | 02 Jun 2020 | |
Pulmonary Fibrosis | Preclinical | India | 01 Jun 2020 |